Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01595802 · ClinicalTrials.gov registry record
Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm
A clinical trial, sponsored by Jan Medical.
- Completed
- Registry status
- 92
- Enrollment target
NCT01595802: Completed study, sponsored by Jan Medical.
NCT01595802 is a clinical trial that has completed, run by Jan Medical. The registered enrollment target is 92 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01595802 has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 92 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the sensitivity, specificity and predictive values of the Jan Medical NeuroWave System in detecting moderate and severe vasospasm in comparison to Trans Cranial Doppler(TCD).
Primary Outcome
Outcome determine Upon completion of study and unmaksing
Interventions
- DEVICE Transcranial Doppler (TCD)
- DEVICE Nautilus NeuroWave
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2012-01 |
| Est. Completion | 2015-07 |
What the finished NCT01595802 record still lists
NCT01595802 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 92 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Doppler (TCD) is the first listed.
NCT01595802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01595802 about?
NCT01595802 is a clinical study titled "Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm". The purpose of the study is to determine the sensitivity, specificity and predictive values of the Jan Medical NeuroWave System in detecting moderate and severe vasospasm in comparison to Trans Cranial Doppler(TCD).
What is the current status of trial NCT01595802?
This trial is currently completed. The enrollment target is 92 participants. The study started on 2012-01. Estimated completion is 2015-07.
What interventions are being tested in trial NCT01595802?
The interventions under investigation include: Transcranial Doppler (TCD) (DEVICE), Nautilus NeuroWave (DEVICE).
Who is sponsoring clinical trial NCT01595802?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia